The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of neoadjuvant chemotherapy on pathologic outcomes in patients with upper tract urothelial carcinoma undergoing extirpative surgery.
 
Nima Almassi
No Relationships to Disclose
 
Tianming Gao
No Relationships to Disclose
 
Byron Lee
No Relationships to Disclose
 
Robert Stein
No Relationships to Disclose
 
Georges-Pascal Haber
Consulting or Advisory Role - Merck
Patents, Royalties, Other Intellectual Property - Cleveland Clinic
 
Moshe Chaim Ornstein
No Relationships to Disclose
 
Brian I. Rini
Consulting or Advisory Role - Corvus Pharmaceuticals; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Timothy D. Gilligan
Travel, Accommodations, Expenses - WellPoint
 
Jorge A. Garcia
Consulting or Advisory Role - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation; Pfizer; Sanofi
Speakers' Bureau - Bayer; Genentech/Roche; Medivation/Astellas; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Lilly (Inst); Orion (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation/Astellas; Pfizer; Sanofi
 
Andrew J. Stephenson
Speakers' Bureau - Genomic Health
 
Petros Grivas
Consulting or Advisory Role - AstraZeneca; Bayer; Biocept; Bristol-Myers Squibb; Clovis Oncology; Dendreon; EMD Serono; Exelixis; Genentech; Merck
Speakers' Bureau - Bristol-Myers Squibb; Genentech
Research Funding - AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst); Pfizer (Inst)